3 курс / Фармакология / Лекарственные_средства,_применяемые_в_акушерстве_и_гинекологии,
.pdfɁɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
ɡɚɬɟɦ ɜɧɭɬɪɶ |
0,2–0,4 ɝ |
0,4 ɝ |
ɜɧɭɬɪɶ |
3 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɐɢɩɪɨɮɥɨɤɫɚɰɢɧ |
0,4–0,6 ɝ |
0,8–1,2 ɝ |
ɜ/ɜ |
3 ɫɭɬ |
|
|
|
(«Ʉɜɢɧɬɨɪ», «ɐɢɩɪɨ- |
|
|
|
|
|
|
|
ɛɚɣ», «ɐɢɩɪɨɥɟɬ») |
|
|
|
|
|
|
|
ɡɚɬɟɦ ɜɧɭɬɪɶ |
0,25–0,75 ɝ |
0,5–0,75 ɝ |
ɜɧɭɬɪɶ |
5–6 ɫɭɬ |
|
|
|
|
|
|
|
|
|
|
+ |
|
|
|
|
|
|
|
|
Ʉɥɢɧɞɚɦɢɰɢɧ |
0,3 ɝ |
0,9 ɝ |
ɜ/ɦ |
5–6 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ʌɢɧɤɨɦɢɰɢɧ |
0,6 ɝ |
1,8 ɝ |
ɜ/ɦ |
5–6 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ɇɟɬɪɨɧɢɞɚɡɨɥ |
0,5 ɝ |
1–1,5 ɝ |
ɜɧɭɬɪɶ |
5–6 ɫɭɬ |
|
|
ɢɥɢ |
|
|
|
|
|
ɗɮɮɟɤɬɢɜɧɵ ɩɪɢ ɧɚ- |
|
|
Ɋɨɤɫɢɬɪɨɦɢɰɢɧ («Ɋɭ- |
0,3 ɝ |
0,3 ɝ |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
ɥɢɱɢɢ ɯɥɚɦɢɞɢɨɡɚ, |
|
|
ɥɢɞ») |
|
|
|
|
ɦɢɤɨɩɥɚɡɦɨɡɚ ɢ ɭɪɟɚ- |
|
|
ɢɥɢ |
|
|
|
|
ɩɥɚɡɦɨɡɚ |
|
|
ɋɩɢɪɚɦɢɰɢɧ («Ɋɨɜɚɦɢ- |
1 500 000– |
4 500 000– |
ɜ/ɜ |
3 ɫɭɬ |
|
|
|
ɰɢɧ» |
3 000 000 ȿȾ |
6 000 000 |
|
|
|
|
|
|
|
ȿȾ |
|
|
|
|
|
ɡɚɬɟɦ ɜɧɭɬɪɶ |
1 500 000– |
4 500 000– |
ɜɧɭɬɪɶ |
3 ɫɭɬ |
|
|
|
ɢɥɢ |
3 000 000 ȿȾ |
6 000 000 |
|
|
|
|
|
|
|
ȿȾ |
|
|
|
|
|
Ⱦɠɨɡɚɦɢɰɢɧ («ȼɢɥɶɩ- |
0,5 ɝ |
1–1,5 ɝ |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
|
|
|
ɪɨɮɟɧ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ɄɈɆɉɅȿɄɋɇȺə ɂɇɎɍɁɂɈɇɇȺə ɌȿɊȺɉɂə |
|
|
ɉɪɨɞɨɥɠɢɬɟɥɶɧɨɫɬɶ ɢ |
||
|
I. ɉɪɟɩɚɪɚɬɵ ɞɥɹ ɤɨɪɪɟɤɰɢɢ ɜɨɞɧɨ-ɷɥɟɤɬɪɨɥɢɬɧɵɯ ɧɚɪɭɲɟɧɢɣ |
|
ɨɛɴɟɦ ɬɟɪɚɩɢɢ ɨɩɪɟ- |
||||
|
|
|
|
|
|
|
|
192
6 Раздел
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
Ⱦɟɤɫɬɪɨɡɚ 5% ɪ-ɪ (ɝɥɸ- |
400 ɦɥ |
400– |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
|
ɞɟɥɹɸɬɫɹ ɬɹɠɟɫɬɶɸ |
|
|
ɤɨɡɚ) |
|
800 ɦɥ |
|
|
ɡɚɛɨɥɟɜɚɧɢɹ |
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɏɥɨɪɢɞ ɧɚɬɪɢɹ |
400 ɦɥ |
400– |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
|
|
|
|
0,9% ɪ-ɪ |
|
800 ɦɥ |
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɉɨɜɢɞɨɧ 8000+ɧɚɬɪɢɹ |
200–400 ɦɥ |
200– |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
|
|
|
|
ɯɥɨɪɢɞ+ɤɚɥɢɹ ɯɥɨ- |
|
400 ɦɥ |
|
|
|
|
|
ɪɢɞ+ɤɚɥɶɰɢɹ ɯɥɨ- |
|
|
|
|
|
|
|
ɪɢɞ+ɦɚɝɧɢɹ ɯɥɨ- |
|
|
|
|
|
|
|
ɪɢɞ+ɧɚɬɪɢɹ ɝɢɞɪɨɤɚɪ- |
|
|
|
|
|
|
|
ɛɨɧɚɬ («Ƚɟɦɨɞɟɡ-ɇ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ⱦɟɤɫɬɪɚɧ [ɫɪɟɞɧɹɹ ɦɨ- |
400 ɦɥ |
400 ɦɥ |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
|
|
|
|
ɥɟɤɭɥɹɪɧɚɹ ɦɚɫɫɚ |
|
|
|
|
|
|
|
30 000–40 000] («Ɋɟɨ- |
|
|
|
|
|
|
|
ɩɨɥɢɝɥɸɤɢɧ») ɪ-ɪ |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ƚɢɞɪɨɤɫɢɷɬɢɥɤɪɚɯɦɚɥ |
250–500 ɦɥ |
500 ɦɥ |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
|
|
|
|
6–10% ɪ-ɪ («Ɋɟɮɨɪɬɚɧ |
|
|
|
|
|
|
|
ȽɗɄ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
ɇɚɬɪɢɹ ɚɰɟɬɚɬ+ɧɚɬɪɢɹ |
400 ɦɥ |
400 ɦɥ |
ɜ/ɜ |
|
|
|
|
ɯɥɨɪɢɞ+ɧɚɬɪɢɹ ɚɰɟ- |
|
|
|
|
|
|
|
ɬɚɬ+ɧɚɬɪɢɹ ɯɥɨ- |
|
|
|
|
|
|
|
ɪɢɞ+ɤɚɥɢɹ ɯɥɨɪɢɞ |
|
|
|
|
|
|
|
|
|
|
|
|
|
193 ...заболеваний инфекционных терапии при применяемые ЛС,
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
(«ɏɥɨɫɨɥɶ») ɪ-ɪ |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɇɚɬɪɢɹ ɚɰɟɬɚɬ+ɧɚɬɪɢɹ |
400 ɦɥ |
400 ɦɥ |
ɜ/ɜ |
|
|
|
|
ɯɥɨɪɢɞ («Ⱦɢɫɨɥɶ») ɪ-ɪ |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɇɚɬɪɢɹ ɝɢɞɪɨɤɚɪɛɨ- |
400 ɦɥ |
400 ɦɥ |
ɜ/ɜ |
|
|
|
|
ɧɚɬ+ɧɚɬɪɢɹ ɯɥɨ- |
|
|
|
|
|
|
|
ɪɢɞ+ɤɚɥɢɹ ɯɥɨɪɢɞ |
|
|
|
|
|
|
|
(«Ɍɪɢɫɨɥɶ») ɪ-ɪ |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɇɚɬɪɢɹ ɯɥɨɪɢɞɚ ɪɚɫ- |
400 ɦɥ |
400 ɦɥ |
ɜ/ɜ |
|
|
|
|
ɬɜɨɪ ɫɥɨɠɧɵɣ (ɤɚɥɢɹ |
|
|
|
|
|
|
|
ɯɥɨɪɢɞ+ɤɚɥɶɰɢɹ ɯɥɨ- |
|
|
|
|
|
|
|
ɪɢɞ+ɧɚɬɪɢɹ ɯɥɨɪɢɞ — |
|
|
|
|
|
|
|
ɪɚɫɬɜɨɪ Ɋɢɧɝɟɪɚ) |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɇɚɬɪɢɹ ɥɚɤɬɚɬɚ ɪɚɫɬɜɨɪ |
400 ɦɥ |
400 ɦɥ |
ɜ/ɜ |
|
|
|
|
ɫɥɨɠɧɵɣ (ɤɚɥɢɹ ɯɥɨ- |
|
|
|
|
|
|
|
ɪɢɞ+ɤɚɥɶɰɢɹ ɯɥɨ- |
|
|
|
|
|
|
|
ɪɢɞ+ɧɚɬɪɢɹ ɯɥɨ- |
|
|
|
|
|
|
|
ɪɢɞ+ɧɚɬɪɢɹ ɥɚɤɬɚɬ — |
|
|
|
|
|
|
|
ɪɚɫɬɜɨɪ ɏɚɪɬɦɚɧɚ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
II. ɉɥɚɡɦɨɡɚɦɟɳɚɸɳɢɟ ɩɪɟɩɚɪɚɬɵ |
|
|
|
ɉɪɢ ɤɪɨɜɨɬɟɱɟɧɢɢ ɢ |
||
|
|
Ⱦɟɤɫɬɪɚɧ [ɫɪɟɞɧɹɹ ɦɨ- |
400 ɦɥ |
ɦɚɤɫɢ- |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
|
ɜɵɪɚɠɟɧɧɨɣ ɝɢɩɨɤɨɚ- |
|
|
ɥɟɤɭɥɹɪɧɚɹ ɦɚɫɫɚ |
|
ɦɚɥɶɧɨ ɞɨ |
|
|
ɝɭɥɹɰɢɢ |
|
|
30 000–40 000] («Ɋɟɨ- |
|
1500 |
|
|
|
|
|
|
|
|
|
|
|
194
6 Раздел
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
|
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
|
ɩɨɥɢɝɥɸɤɢɧ») ɪ-ɪ |
|
ɦɥ/ɫɭɬ |
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
Ⱦɟɤɫɬɪɚɧ [ɫɪɟɞɧɹɹ ɦɨ- |
400 ɦɥ |
ɦɚɤɫɢ- |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
|
|
|
|
|
ɥɟɤɭɥɹɪɧɚɹ ɦɚɫɫɚ |
|
ɦɚɥɶɧɨ ɞɨ |
|
|
|
|
|
|
50 000–70 000] («ɉɨɥɢ- |
|
2000 |
|
|
|
|
|
|
ɝɥɸɤɢɧ») ɪ-ɪ |
|
ɦɥ/ɫɭɬ |
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
Ⱦɟɤɫɬɪɚɧ [ɫɪɟɞɧɹɹ ɦɨ- |
400 ɦɥ |
ɦɚɤɫɢ- |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
|
|
|
|
|
ɥɟɤɭɥɹɪɧɚɹ ɦɚɫɫɚ |
|
ɦɚɥɶɧɨ ɞɨ |
|
|
|
|
|
|
30 000–40 000] («Ɋɟɨ- |
|
1500 |
|
|
|
|
|
|
ɦɚɤɪɨɞɟɤɫ» 10% ɪ-ɪ ɫ |
|
ɦɥ/ɫɭɬ |
|
|
|
|
|
|
ɧɚɬɪɢɹ ɯɥɨɪɢɞɨɦ) |
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
Ƚɢɞɪɨɤɫɢɷɬɢɥɤɪɚɯɦɚɥ |
250–500 ɦɥ |
500 ɦɥ |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
|
|
|
|
|
6–10% ɪ-ɪ («Ɋɟɮɨɪɬɚɧ |
|
|
|
|
|
|
|
|
ȽɗɄ») |
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
Ⱥɥɶɛɭɦɢɧ 10% ɪ-ɪ |
100 ɦɥ |
100– |
|
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
|
|
|
|
|
|
200 ɦɥ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
|
ɀɟɥɚɬɢɧ («ɀɟɥɚɬɢ- |
400 ɦɥ |
800– |
|
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
|
|
|
|
ɧɨɥɶ») |
|
1200 |
ɦɥ |
|
|
|
|
|
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
Ⱦɨɡɚ ɡɚɜɢɫɢɬ ɨɬ ɫɨ- |
|
|
ɋɜɟɠɟɡɚɦɨɪɨɠɟɧɧɚɹ |
400 ɦɥ |
1200 |
ɦɥ ɢ |
|
|
|
|
|
ɩɥɚɡɦɚ |
|
ɛɨɥɟɟ |
|
|
ɫɬɨɹɧɢɹ ɝɟɦɨɫɬɚɡɚ |
|
|
|
|
|
|
|
|
|
|
195 ...заболеваний инфекционных терапии при применяемые ЛС,
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
ɄɈɊɊȿɄɐɂə ɇȺɊɍɒȿɇɂɃ |
ȼ ɋɂɋɌȿɆȿ |
ȽȿɆɈɋɌȺɁȺ |
|
ɉɪɨɞɨɥɠɢɬɟɥɶɧɨɫɬɶ |
||
|
I. Ⱥɧɬɢɤɨɚɝɭɥɹɧɬɵ |
|
|
|
|
ɤɭɪɫɚ ɨɩɪɟɞɟɥɹɟɬɫɹ |
|
|
|
|
|
|
|
|
ɢɧɞɢɜɢɞɭɚɥɶɧɨ. |
|
|
Ƚɟɩɚɪɢɧ ɧɚɬɪɢɹ |
5000 ȿȾ |
10–15 000 |
ɩ/ɤ |
|
|
|
|
ɢɥɢ |
|
ȿȾ |
|
|
|
|
|
Ⱦɚɥɬɟɩɚɪɢɧ ɧɚɬɪɢɹ |
0,3 ɦɥ |
0,3–0,6 ɦɥ |
ɩ/ɤ |
|
|
|
|
(«Ɏɪɚɝɦɢɧ») |
|
|
|
|
ɉɪɨɬɢɜɨɬɪɨɦɛɨɬɢɱɟ- |
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɇɚɞɪɨɩɚɪɢɧ ɤɚɥɶɰɢɹ |
0,3 ɦɥ |
0,3–0,6 ɦɥ |
ɩ/ɤ |
|
ɫɤɭɸ ɬɟɪɚɩɢɸ ɪɟɤɨ- |
|
|
(«Ɏɪɚɤɫɢɩɚɪɢɧ») |
|
|
|
|
ɦɟɧɞɭɟɬɫɹ ɫɨɱɟɬɚɬɶ ɫ |
|
|
ɢɥɢ |
|
|
|
|
ɜɨɫɩɨɥɧɟɧɢɟɦ ɭɪɨɜɧɹ |
|
|
ɗɧɨɤɫɚɩɚɪɢɧ ɧɚɬɪɢɹ |
0,2 ɦɥ |
0,2 ɦɥ |
ɩ/ɤ |
|
ɚɧɬɢɬɪɨɦɛɢɧɚ III ɢ |
|
|
(«Ʉɥɟɤɫɚɧ») |
|
|
|
|
ɩɥɚɡɦɢɧɨɝɟɧɚ ɡɚ ɫɱɟɬ |
|
|
|
|
|
|
|
ɩɟɪɟɥɢɜɚɧɢɹ ɫɜɟɠɟɡɚ- |
|
|
|
|
|
|
|
ɦɨɪɨɠɟɧɧɨɣ ɩɥɚɡɦɵ |
|
II. |
Ⱦɟɡɚɝɪɟɝɚɧɬɵ |
|
|
|
|
|
|
|
Ⱦɢɩɢɪɢɞɚɦɨɥ («Ʉɭɪɚɧ- |
0,025 ɝ |
0,075 ɝ |
ɜɧɭɬɪɶ |
|
|
|
|
ɬɢɥ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɉɟɧɬɨɤɫɢɮɢɥɥɢɧ |
0,4 ɝ |
0,8 ɝ |
ɜɧɭɬɪɶ |
|
|
|
|
(«Ⱥɝɚɩɭɪɢɧ ɪɟɬɚɪɞ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ⱥɰɟɬɢɥɫɚɥɢɰɢɥɨɜɚɹ ɤɢ- |
0,05–0,1 ɝ |
0,05–0,1 ɝ |
ɜɧɭɬɪɶ |
|
|
|
|
ɫɥɨɬɚ («Ɍɪɨɦɛɨ Ⱥɋɋ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
III. |
Ƚɟɦɨɫɬɚɬɢɱɟɫɤɢɟ ɩɪɟ- |
|
|
|
|
ɉɪɢ ɜɨɡɧɢɤɧɨɜɟɧɢɢ |
|
ɩɚɪɚɬɵ |
|
|
|
|
ɤɪɨɜɨɬɟɱɟɧɢɣ, ɨɛɭ- |
|
|
|
|
|
|
|
|
ɫɥɨɜɥɟɧɧɵɯ ɜɵɫɨɤɨɣ |
|
|
ɗɬɚɦɡɢɥɚɬ («Ⱦɢɰɢɧɨɧ») |
2 ɦɥ |
4–8 ɦɥ |
ɜ/ɜ |
|
196
6 Раздел
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
|
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
|
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
ɮɢɛɪɢɧɨɥɢɬɢɱɟɫɤɨɣ |
|
|
Ɍɪɚɧɫɚɦɱɚ |
5 ɦɥ |
5–10 ɦɥ |
ɜ/ɜ |
|
|
ɚɤɬɢɜɧɨɫɬɶɸ ɩɥɚɡɦɵ |
|
|
ȽɅɘɄɈɄɈɊɌɂɄɈɂȾɕ |
|
|
|
|
|
|
|
|
ɉɪɟɞɧɢɡɨɥɨɧ |
0,05–0,15 ɝ |
0,3–1,2 ɝ ɢ |
ɜ/ɜ |
|
|
Ⱦɨɡɚ ɩɪɟɩɚɪɚɬɚ ɨɩɪɟ- |
|
|
|
|
ɜɵɲɟ |
|
|
|
ɞɟɥɹɟɬɫɹ ɢɧɞɢɜɢɞɭ- |
|
|
ɢɥɢ |
|
|
|
|
|
ɚɥɶɧɨ ɜ ɡɚɜɢɫɢɦɨɫɬɢ |
|
|
Ƚɢɞɪɨɤɨɪɬɢɡɨɧ |
0,05–0,15 ɝ |
1,0–1,3 ɝ ɢ |
ɜ/ɜ |
|
|
ɨɬ ɭɪɨɜɧɹ ȺȾ |
|
|
|
|
ɜɵɲɟ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ɉɊȿɉȺɊȺɌɕ ȾɅə ɉɈȾȾȿɊɀȺɇɂə ɋȿɊȾȿɑɇɈɃ ȾȿəɌȿɅɖɇɈɋɌɂ |
|
Ⱦɨɡɚ ɩɪɟɩɚɪɚɬɚ ɨɩɪɟ- |
||||
|
|
Ⱦɨɩɚɦɢɧ |
1,5–3,5 |
|
ɜ/ɜ ɤɚɩɟɥɶɧɨ, |
|
|
ɞɟɥɹɟɬɫɹ ɢɧɞɢɜɢɞɭ- |
|
|
|
ɦɤɝ/(ɤɝ·ɦɢɧ) |
|
ɞɨɡɚ ɢɧɞɢɜɢɞɭ- |
|
|
ɚɥɶɧɨ ɞɨ ɫɬɚɛɢɥɢɡɚ- |
|
|
|
|
|
ɚɥɶɧɚ |
|
|
ɰɢɢ ȺȾ. |
|
|
ɢɥɢ |
|
|
|
|
|
Ʉɪɢɬɟɪɢɟɦ ɚɞɟɤɜɚɬɧɨ- |
|
|
Ⱦɨɛɭɬɚɦɢɧ («Ⱦɨɛɭɬ- |
10–20 |
|
|
|
|
ɫɬɢ ɞɨɡɵ ɫɥɭɠɢɬ ɞɢɭ- |
|
|
ɪɟɤɫ») |
ɦɤɝ/(ɤɝ·ɦɢɧ) |
|
|
|
|
ɪɟɡ, ɩɪɟɜɵɲɚɸɳɢɣ |
|
|
ɢɥɢ |
|
|
|
|
|
40 ɦɥ/ɱ |
|
|
ɇɨɪɷɩɢɧɟɮɪɢɧ («ɇɨ- |
2–5 |
|
|
|
|
|
|
|
ɪɚɞɪɟɧɚɥɢɧ») |
ɦɤɝ/(ɤɝ·ɦɢɧ) |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
ɇɢɤɟɬɚɦɢɞ («Ʉɨɪɞɢɚ- |
1–2 ɦɥ |
2–4 ɦɥ |
ɩ/ɤ |
|
|
|
|
|
ɦɢɧ») |
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
ɋɭɥɶɮɨɤɚɦɮɨɪɧɚɹ ɤɢ- |
2 ɦɥ |
4–6 ɦɥ |
ɜ/ɦ |
|
|
|
|
|
ɫɥɨɬɚ+ɩɪɨɤɚɢɧ («ɋɭɥɶ- |
|
|
|
|
|
|
|
|
ɮɨɤɚɦɮɨɤɚɢɧ») |
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
197 ...заболеваний инфекционных терапии при применяемые ЛС,
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
Ⱦɢɝɨɤɫɢɧ |
0,25 ɦɝ |
0,25– |
ɜ/ɜ |
|
|
|
|
|
|
0,5 ɦɥ |
|
|
|
|
ɄɈɊɊȿɄɐɂə ȾɕɏȺɌȿɅɖɇɈɃ ɇȿȾɈɋɌȺɌɈɑɇɈɋɌɂ |
|
|
||||
|
|
ɂɧɜɚɡɢɜɧɚɹ ɢ ɧɟɢɧɜɚɡɢɜɧɚɹ ɢɫɤɭɫɫɬɜɟɧɧɚɹ ɜɟɧɬɢɥɹɰɢɹ ɥɟɝɤɢɯ |
|
|
|||
|
|
ȾɂɍɊȿɌɂɄɂ ȾɅə Ʌȿɑȿɇɂə ɈɅɂȽɍɊɂɂ |
|
|
Ⱦɨ ɞɨɫɬɢɠɟɧɢɹ ɩɨɱɚ- |
||
|
|
Ɏɭɪɨɫɟɦɢɞ («Ʌɚɡɢɤɫ») |
10–40 ɦɝ |
ɞɨ 200 ɦɝ |
ɜ/ɜ |
|
ɫɨɜɨɝɨ ɞɢɭɪɟɡɚ ɧɟ ɦɟ- |
|
|
|
|
|
|
|
ɧɟɟ 30–60 ɦɥ/ɱ |
|
+ |
|
|
|
|
|
|
|
|
Ɇɚɧɧɢɬɨɥ («Ɇɚɧɧɢɬ») |
1–1,5 ɝ/ɤɝ |
ɞɨ 140 ɝ |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
|
|
|
|
15% ɪ-ɪ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ɂɆɆɍɇɈɌȿɊȺɉɂə |
|
|
|
|
|
|
|
ɂɦɦɭɧɨɝɥɨɛɭɥɢɧ ɱɟɥɨ- |
0,25–0,5 ɝ/ɤɝ |
0,25– |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
3 ɜɜɟɞɟɧɢɹ ɱɟɪɟɡ |
|
|
|
ɜɟɤɚ ɧɨɪɦɚɥɶɧɵɣ ɞɥɹ |
|
0,5 ɝ/ɤɝ |
|
ɫɭɬɤɢ |
|
|
|
ɜɧɭɬɪɢɜɟɧɧɨɝɨ ɜɜɟɞɟ- |
|
|
|
|
|
|
|
ɧɢɹ, ɠɢɞɤɢɣ |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɂɧɬɟɪɮɟɪɨɧ ɚɥɶɮɚ-2 |
500 000– |
500 000– |
ɪɟɤɬɚɥɶɧɵɟ |
10 ɫɭɬ |
|
|
|
(«ȼɢɮɟɪɨɧ», «Ƚɟɧɮɟ- |
1 000 000 Ɇȿ |
1 000 000 |
ɫɜɟɱɢ |
|
|
|
|
ɪɨɧ», «Ʉɢɩɮɟɪɨɧ») |
|
Ɇȿ |
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɂɦɦɭɧɨɦɨɞɭɥɹɬɨɪɵ |
|
|
|
|
|
|
|
|
Ⱥɪɝɟɧɢɥ-ɚɥɶɮɚ- |
1 ɦɥ |
1 ɦɥ |
ɜ/ɦ |
5–10 ɫɭɬ |
|
|
|
ɚɫɩɚɪɬɢɥ-ɥɢɡɢɥ-ɜɚɥɢɥ- |
|
|
|
|
|
|
|
ɬɢɪɨɡɢɥ-ɚɪɝɟɧɢɧ |
|
|
|
|
|
|
|
(«ɂɦɭɧɨɮɚɧ») |
|
|
|
|
|
|
|
0,005% ɪ-ɪ |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
|
|
|
|
|
198
6 Раздел
Ɂɚɛɨɥɟɜɚɧɢɟ, |
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
|
ɨɫɧɨɜɧɨɣ |
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
«Ʌɢɤɨɩɢɞ» |
0,001 ɝ |
0,002– |
ɩɨɞ ɹɡɵɤ |
10 ɫɭɬ |
|
|
|
|
0,01 ɝ |
0,003 ɝ |
ɜɧɭɬɪɶ |
|
|
|
|
|
|
0,2–0,3 ɝ |
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɇɚɬɪɢɹ ɪɢɛɨɧɭɤɥɟɚɬ |
0,5 ɦɥ |
0,5–1 ɦɥ |
ɜ/ɦ |
5 ɢɧɴɟɤɰɢɣ ɱɟɪɟɡ |
|
|
|
(«Ɋɢɞɨɫɬɢɧ») |
|
|
|
ɞɟɧɶ |
|
|
|
ɢɥɢ |
|
|
|
5 ɢɧɴɟɤɰɢɣ ɱɟɪɟɡ |
|
|
|
Ɇɟɝɥɭɦɢɧɚ ɚɤɪɢɞɨɧ- |
0,25 ɝ |
0,25 ɝ |
ɜ/ɦ |
ɞɟɧɶ |
|
|
|
ɚɰɟɬɚɬ («ɐɢɤɥɨɮɟɪɨɧ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
ȾȿɋȿɇɋɂȻɂɅɂɁɂɊɍɘɓȺə ɌȿɊȺɉɂə
|
|
Ⱦɢɮɟɧɝɢɞɪɚɦɢɧ («Ⱦɢ- |
1 ɦɥ |
2–3 ɦɥ |
ɜ/ɦ |
12–15 ɫɭɬ |
|
|
|
ɦɟɞɪɨɥ») 1% ɪ-ɪ |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɉɪɨɦɟɬɚɡɢɧ («Ⱦɢɩɪɚ- |
2 ɦɥ |
4 ɦɥ |
ɜ/ɦ |
12–15 ɫɭɬ |
|
|
|
ɡɢɧ», «ɉɢɩɨɥɶɮɟɧ») |
|
|
|
|
|
|
|
2,5% ɪ-ɪ ɢɥɢ ɜɧɭɬɪɶ |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɏɥɨɪɨɩɢɪɚɦɢɧ («ɋɭɩ- |
1 ɦɥ |
2 ɦɥ |
ɜ/ɦ |
12–15 ɫɭɬ |
|
|
|
ɪɚɫɬɢɧ») 2% ɪ-ɪ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ɋɉȺɁɆɈɅɂɌɂɄɂ |
|
|
|
|
|
|
|
Ⱦɪɨɬɚɜɟɪɢɧ («ɇɨ-ɲɩɚ») |
2 ɦɥ |
4–8 ɦɥ |
ɜ/ɜ, ɜ/ɦ |
7–10 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɉɚɩɚɜɟɪɢɧ |
2 ɦɥ |
2–4 ɦɥ |
ɜ/ɜ, ɜ/ɦ |
7–10 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɉɥɚɬɢɮɢɥɥɢɧ |
1 ɦɥ |
2–3 ɦɥ |
ɜ/ɦ |
7–10 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
|
|
|
|
|
199 ...заболеваний инфекционных терапии при применяемые ЛС,
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
|
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
|
200 |
|
|
|
|
|||||||
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
|
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
|
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
|
|
|
Ⱥɬɪɨɩɢɧ |
|
0,5–1 ɦɥ |
1–2 ɦɥ |
ɜ/ɦ |
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
|
|
«Ɇɟɬɚɰɢɧ» |
|
0,5–1 ɦɥ |
1–2 ɦɥ |
ɜ/ɦ |
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
|
|
Ɇɟɬɚɦɢɡɨɥ ɧɚɬɪɢɹ |
|
5–10 ɦɥ |
10–15 ɦɥ |
ɜ/ɜ, ɜ/ɦ |
|
|
|
|
|
|
(«Ȼɚɪɚɥɝɢɧ Ɇ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ɉɊȿɉȺɊȺɌɕ ȾɅə ɉɊɈɎɂɅȺɄɌɂɄɂ ɂ Ʌȿɑȿɇɂə ȾɂɋȻȺɄɌȿɊɂɈɁȺ |
|
|
|
||||||
|
|
Ɏɥɭɤɨɧɚɡɨɥ («Ⱦɢɮɥɸ- |
|
0,1 ɝ |
0,1 ɝ |
ɜ/ɜ |
1 ɪɚɡ ɜ 7 ɞɧɟɣ |
Ɂɚɜɢɫɢɬ ɨɬ ɩɪɨɞɨɥɠɢ- |
|
|
|
|
ɤɚɧ», «Ɏɥɸɤɨɫɬɚɬ») |
|
|
|
|
|
ɬɟɥɶɧɨɫɬɢ ɚɧɬɢɛɚɤɬɟ- |
|
|
|
|
ɢ ɜɧɭɬɪɶ |
|
0,15 ɝ |
0,15 ɝ |
ɜɧɭɬɪɶ |
1 ɪɚɡ ɜ 7 ɞɧɟɣ |
ɪɢɚɥɶɧɨɣ ɬɟɪɚɩɢɢ |
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
|
|
ɇɢɫɬɚɬɢɧ |
|
500 000 ȿȾ |
2 000 000– |
ɜɧɭɬɪɶ |
10–12 ɫɭɬ |
|
|
|
|
|
|
|
|
3 000 000 |
|
|
|
|
|
|
|
|
|
|
ȿȾ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ɉɅȺɁɆȺɎȿɊȿɁ ɂ ȾɊɍȽɂȿ ɆȿɌɈȾɕ |
|
|
|
|
|
|
||
|
ɗɄɋɌɊȺɄɈɊɉɈɊȺɅɖɇɈɃ ȾȿɌɈɄɋɂɄȺɐɂɂ |
|
|
|
|
|
||||
|
|
|
|
|
||||||
Ɉ87 ɉɨɜɟɪɯɧɨ- |
Ɍɟɪɚɩɢɹ ɜɤɥɸɱɚɟɬ ɩɪɨɬɢɜɨɜɨɫɩɚɥɢɬɟɥɶɧɵɟ Ʌɋ ɜ ɫɨɱɟɬɚɧɢɢ ɫ ɞɟɡɚɝɪɟɝɚɧɬɚɦɢ, ɜɟɧɨɬɨɧɢɤɚɦɢ, |
ɚɧɝɢɨɩɪɨɬɟɤɬɨɪɚɦɢ ɢ |
|
|
||||||
ɫɬɧɵɣ ɬɪɨɦɛɨ- |
Ʌɋ, ɭɥɭɱɲɚɸɳɢɦɢ ɦɢɤɪɨɰɢɪɤɭɥɹɰɢɸ |
|
|
|
|
|
|
|||
ɮɥɟɛɢɬ ɜ ɩɨɫɥɟ- |
|
|
|
|
|
|
|
|
||
ɈȻɓȿȿ Ʌȿɑȿɇɂȿ |
|
|
|
|
|
|
|
|||
ɪɨɞɨɜɨɦ ɩɟɪɢɨ- |
ɉɪɨɬɢɜɨɜɨɫɩɚɥɢɬɟɥɶɧɵɟ Ʌɋ |
|
|
|
|
|
|
|
||
ɞɟ |
|
|
|
|
|
|
|
|
|
|
|
Ⱦɢɤɥɨɮɟɧɚɤ («ȼɨɥɶɬɚ- |
|
0,05 ɝ |
0,1–0,15 ɝ |
ɜɧɭɬɪɶ |
10–15 ɫɭɬ |
|
|
|
|
|
|
ɪɟɧ», «Ɉɪɬɨɮɟɧ») |
|
|
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Раздел |
|
|
Ɏɟɧɢɥɛɭɬɚɡɨɧ («Ȼɭɬɚ- |
|
0,15 ɝ |
0,45 ɝ |
ɜɧɭɬɪɶ |
10–15 ɫɭɬ |
|
|
|
|
|
ɞɢɨɧ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ȾȿɁȺȽɊȿȽȺɇɌɕ |
|
|
|
|
|
|
|
6 |
|
|
|
|
|
|
|
|
|
|
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
Ʉɫɚɧɬɢɧɨɥɚ ɧɢɤɨɬɢɧɚɬ |
0,15 ɝ |
0,45 ɝ |
ɜɧɭɬɪɶ |
7–10 ɫɭɬ |
|
|
|
(«Ɍɟɨɧɢɤɨɥ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ⱦɢɩɢɪɢɞɚɦɨɥ («Ʉɭɪɚɧ- |
0,025 ɝ |
0,075 ɝ |
ɜɧɭɬɪɶ |
7–10 ɫɭɬ |
|
|
|
ɬɢɥ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɉɟɧɬɨɤɫɢɮɢɥɥɢɧ |
0,1 ɝ |
0,3 ɝ |
ɜɧɭɬɪɶ |
7–10 ɫɭɬ |
|
|
|
(«Ⱥɝɚɩɭɪɢɧ ɪɟɬɚɪɞ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ⱥɰɟɬɢɥɫɚɥɢɰɢɥɨɜɚɹ ɤɢ- |
0,125 ɝ |
0,125– |
ɜɧɭɬɪɶ |
7–10 ɫɭɬ |
|
|
|
ɫɥɨɬɚ («Ⱥɫɩɢɪɢɧ», |
|
0,25 ɝ |
|
|
|
|
|
«Ɍɪɨɦɛɨ Ⱥɋɋ») |
0,05 ɝ |
0,05–0,1 ɝ |
ɜɧɭɬɪɶ |
7–10 ɫɭɬ |
|
|
|
|
|
|
|
|
|
|
ɋɊȿȾɋɌȼȺ, ɍɅɍɑɒȺɘɓɂȿ ɆɂɄɊɈɐɂɊɄɍɅəɐɂɘ |
|
|
||||
|
|
Ɍɪɨɤɫɟɪɭɬɢɧ («Ɍɪɨɤɫɟ- |
5 ɦɥ |
5 ɦɥ |
ɜ/ɦ |
5 ɫɭɬ |
|
|
|
ɜɚɡɢɧ»), |
0,3 ɝ |
0,6 ɝ |
ɜɧɭɬɪɶ |
10 ɫɭɬ |
|
|
|
ɡɚɬɟɦ ɜɧɭɬɪɶ |
|
|
|
|
|
|
|
ɢɥɢ |
0,25 ɝ |
0,75 ɝ |
ɜɧɭɬɪɶ |
10–14 ɫɭɬ |
|
|
|
ɗɫɰɢɧ («ɗɫɤɭɡɚɧ 20») |
|
|
|
|
|
|
|
ȼȿɇɈɌɈɇɂɄɂ |
|
|
|
|
|
|
|
Ⱦɢɨɫɦɢɧ+ɝɟɫɩɟɪɢɞɢɧ |
0,5 ɝ |
1–2 ɝ |
ɜɧɭɬɪɶ |
10–14 ɫɭɬ |
|
|
|
(«Ⱦɟɬɪɚɥɟɤɫ») |
|
|
|
|
|
|
|
ɢɥɢ |
0,6 ɝ |
1,2 ɝ |
ɜɧɭɬɪɶ |
10–14 ɫɭɬ |
|
|
|
«Ƚɢɧɤɨɪ ɮɨɪɬ» |
|
|
|
|
|
|
|
ɢɥɢ |
0,4 ɝ |
0,8–1,2 ɝ |
ɜɧɭɬɪɶ |
10–15 ɫɭɬ |
|
|
|
«ɐɢɤɥɨ 3 ɮɨɪɬ» |
|
|
|
|
|
|
|
ȾȿɋȿɇɋɂȻɂɅɂɁɂɊɍɘɓȺə |
ɌȿɊȺɉɂə |
|
|
|
|
201 ...заболеваний инфекционных терапии при применяемые ЛС,